Single-Gene Testing vs Panel Testing vs Whole Exome Sequencing: Choosing the Right Scope

When you’re considering genetic testing, one of the most crucial decisions you’ll face is determining the scope of the test. This isn’t just about choosing a lab; it’s about understanding how much of your genetic information you want to explore. From looking at a single gene to examining nearly all protein-coding genes, each option – single-gene testing, panel testing, and Whole Exome Sequencing (WES) – offers distinct advantages, limitations, and practical implications. Your choice will impact the potential diagnostic yield, the cost, the time frame, and the amount of information you receive, some of which might be unexpected or challenging to interpret. This guide will help you navigate these options, focusing on practical considerations for someone actively comparing genetic testing services, particularly within the Indian context.

Understanding the Different Scopes of Genetic Testing

Before diving into the specifics, it’s essential to grasp the fundamental differences between the types of genetic tests available based on their scope. Each test type targets a different amount of your DNA, leading to varying levels of detail and potential findings.

Single-Gene Testing

Single-gene testing, as the name suggests, focuses on analyzing a specific gene known or suspected to be associated with a particular condition. You typically opt for this test when there’s a strong clinical indication or family history pointing to a mutation in a single, well-characterized gene.

When you might choose it:
You have a clear diagnosis or strong suspicion of a specific monogenic condition (a condition caused by a mutation in a single gene).
There’s a known pathogenic variant in your family, and you want to test for its presence (e.g., carrier screening for a specific condition like Cystic Fibrosis or SMA, or testing for Huntington’s disease).
Confirmation of a diagnosis is needed for prognosis, treatment planning, or reproductive decisions.
Example: Testing for BRCA1/BRCA2 mutations if there’s a strong family history of breast and ovarian cancer.

Pros:
Highly targeted: Provides a definitive answer for a specific suspected condition.
Lower cost: Generally the least expensive option as it involves sequencing a smaller amount of DNA.
Faster turnaround: Results often available sooner than broader tests.
Easier interpretation: The results are usually straightforward and directly related to the suspected condition.

Cons:
Limited scope: Will miss mutations in other genes that might cause similar symptoms or contribute to the condition. If the suspected gene doesn’t reveal a mutation, you may still lack a diagnosis and need further testing.
Diagnostic odyssey: If the initial single-gene test is negative, you might end up needing multiple single-gene tests or broader tests later, increasing overall time and cost.

Panel Testing

Panel testing involves analyzing multiple genes simultaneously that are known to be associated with a particular group of diseases or a phenotype (observable characteristics). These panels can range from a few genes to hundreds, grouped by condition (e.g., cardiomyopathy panel, epilepsy panel, cancer panel).

When you might choose it:
Your symptoms or family history suggest a genetic condition, but several genes could be responsible.
You’re looking for a diagnosis in a heterogeneous disorder where multiple genes can cause the same or similar symptoms.
You’ve already ruled out the most common single-gene causes, or a single-gene test was negative.
Example: A “neuropathy panel” might include dozens of genes linked to various forms of peripheral neuropathy.

Pros:
Broader coverage: Increases the diagnostic yield compared to single-gene testing, as it screens multiple relevant genes at once.
Cost-effective for multiple suspects: Often cheaper than ordering multiple single-gene tests.
Reduced diagnostic odyssey: Can help pinpoint the cause more quickly when multiple genes are implicated.
Focused interpretation: While broader than single-gene, results are still generally focused on a specific clinical area, making interpretation more manageable than WES.

Cons:
Still limited: While broader than single-gene, it only includes genes known to be part of the panel. It will miss pathogenic variants in genes not included on the panel, even if they cause similar symptoms.
Potential for Variants of Uncertain Significance (VUS): Testing more genes increases the chance of finding variants whose clinical significance is not yet known, which can lead to anxiety and further follow-up.
Costlier than single-gene: More expensive due to the larger number of genes sequenced.

Whole Exome Sequencing (WES)

Whole Exome Sequencing (WES) targets the exome, which constitutes about 1-2% of the human genome but contains approximately 85% of known disease-causing mutations. It sequences all protein-coding regions of the genes.

When you might choose it:
You have a suspected genetic condition, but previous single-gene or panel tests have been negative, and a diagnosis remains elusive.
Your clinical presentation is complex, atypical, or overlaps with multiple genetic conditions, making it difficult to select a specific gene or panel.
You have a rare disease, and the causative gene is unknown or newly discovered.
For pediatric cases with severe, early-onset conditions, especially when a rapid diagnosis is critical for management.
Example: A child with intellectual disability, seizures, and unusual facial features without a clear diagnostic path.

Pros:
Most comprehensive for known conditions: Provides the broadest view of protein-coding genes, maximizing the chance of finding a diagnosis, especially for rare or complex conditions.
Future-proofing: The data can be reanalyzed in the future as new genes and disease associations are discovered, potentially yielding a diagnosis without needing a new test.
Discovery of novel genes: Can sometimes lead to the identification of entirely new disease-causing genes.
No specific suspicion needed: Useful when the clinical picture doesn’t point to a single gene or a defined panel.

Cons:
Highest cost: Significantly more expensive than single-gene or panel testing.
Complex interpretation: Generates a vast amount of data, requiring sophisticated bioinformatics and expert clinical interpretation. This increases the chance of finding VUS or incidental findings (unrelated but potentially significant findings).
Turnaround time: Generally the longest turnaround time due to the volume of data and interpretation complexity.
Limitations: WES does not cover non-coding regions, large structural variants, mitochondrial DNA, or repeat expansion disorders effectively, which may still require separate specialized tests. It’s not “whole genome.”

In the discussion of genetic testing options, it’s essential to consider the implications of Single-Gene Testing, Panel Testing, and Whole Exome Sequencing. Each method has its unique advantages and limitations, making it crucial for individuals to choose the right scope based on their specific needs. For a deeper understanding of these testing approaches and their applications, you can refer to a related article that provides comprehensive insights on the topic. To explore more, visit Genetic Test.

Practical Considerations for Your Decision

Choosing the right scope isn’t a purely scientific decision; it’s also a practical one influenced by your circumstances, clinical needs, and resources.

Diagnostic Yield

The diagnostic yield refers to the percentage of individuals who receive a definitive genetic diagnosis from a test.

Single-Gene Testing: High yield if the suspected gene is indeed the cause, but zero yield if it’s not.
Panel Testing: Moderate to high yield, typically ranging from 15-40%, depending on the panel and the condition.
Whole Exome Sequencing: Generally the highest yield for undiagnosed genetic conditions, often 25-50% in symptomatic individuals, and can be higher in specific cohorts like pediatric neurology.

Practical Takeaway: If a strong clinical suspicion exists for a single, well-defined gene, start there. If symptoms are broader, or multiple genes could be involved, a panel offers a good balance. For a complex, undiagnosed condition where other tests have failed, WES provides the best chance of diagnosis.

Cost Implications in India

The cost of genetic testing in India varies significantly based on the scope, the specific lab, and the technology used. These figures are approximate and can change.

Single-Gene Testing: Typically ranges from ₹5,000 to ₹25,000. For instance, common carrier screening for SMA might be around ₹8,000-₹12,000, while a rarer single-gene test could be higher.
Panel Testing: Generally ranges from ₹15,000 to ₹60,000. Smaller panels (e.g., 5-10 genes) might be on the lower end, while large comprehensive panels (e.g., hundreds of genes for a broad cancer susceptibility) can be towards the higher end.
Whole Exome Sequencing (WES): Prices typically start from ₹35,000 for a proband (single individual) and can go up to ₹70,000 or more, especially for trio WES (proband and both parents), which significantly aids interpretation. Some labs may offer rapid WES at a premium.

Practical Takeaway: While WES offers the broadest scope, its upfront cost is highest. Consider if multiple single-gene tests or subsequent panel tests might eventually exceed the cost of an earlier WES, especially if you anticipate a prolonged diagnostic journey. Some labs offer payment plans or financial assistance. Always get a detailed quote before proceeding.

Turnaround Time (TAT)

The time it takes to receive your results is a key factor, especially when a diagnosis is urgent.

Single-Gene Testing: Often the fastest, with TAT ranging from 2-4 weeks.
Panel Testing: Typically 4-8 weeks, depending on the panel size and lab.
Whole Exome Sequencing: Generally the longest, 8-16 weeks is common. Some labs offer “rapid WES” in 2-4 weeks for critical cases (e.g., NICU patients), but at a significantly higher cost.

Practical Takeaway: Discuss the expected TAT with the lab, especially if clinical management decisions are pending. A longer TAT for a comprehensive test might be acceptable if it provides a definitive diagnosis after a long journey, but it’s less ideal for urgent situations unless a rapid option is available.

Interpretation and Genetic Counselling

The complexity of interpreting results increases with the scope of the test.

Single-Gene Testing: Results are usually straightforward – pathogenic variant detected or not.
Panel Testing: May reveal multiple VUS, requiring careful evaluation and often follow-up.
Whole Exome Sequencing: Generates the most data, leading to a higher likelihood of VUS and incidental findings. This requires highly specialized genetic counsellors and clinical geneticists for accurate interpretation and communication.

Practical Takeaway: Regardless of the test scope, pre-test and post-test genetic counselling are crucial. A qualified genetic counsellor can help you understand the implications of each test, manage expectations about potential findings (including VUS and incidental findings), and guide you through the results. In India, access to genetic counsellors is growing, with services available in major metropolitan areas like Mumbai, Delhi, Bengaluru, Hyderabad, and Chennai. Ensure the lab or your referring physician facilitates access to such expertise.

Choosing a Reputable Lab in India

The accuracy and reliability of your genetic test results depend heavily on the quality of the laboratory. When comparing options in India, several factors should guide your decision.

Accreditation Standards

Accreditation ensures that a lab meets rigorous quality and competency standards.

NABL (National Accreditation Board for Testing and Calibration Laboratories): This is the primary accreditation body in India. An NABL-accredited lab adheres to international standards (ISO 15189 for medical laboratories) for quality management systems and technical competence.
CAP (College of American Pathologists): While a US-based accreditation, some advanced Indian labs, especially those catering to international standards or complex genetic tests, might also hold CAP accreditation. This signifies a very high level of quality assurance.

Practical Takeaway: Always prioritize NABL-accredited labs for any genetic testing in India. CAP accreditation is an added bonus for highly specialized services. Do not compromise on accreditation for cost savings, as inaccurate results can have serious medical consequences. You can typically verify a lab’s accreditation status on the NABL or CAP websites.

Experience and Expertise

Consider the lab’s track record and the expertise of its team.

Specialization: Does the lab specialize in the type of genetic testing you need? Some labs excel in specific areas like oncology, prenatal, or rare disease diagnostics.
Bioinformatics and Clinical Interpretation: For panel testing and especially WES, the lab’s bioinformatics pipeline (for processing raw data) and the expertise of its clinical geneticists/scientists (for interpreting variants) are critical. Inquire about their team’s qualifications and experience.
Reporting: A good lab provides a clear, comprehensive, and clinically actionable report. It should explain the detected variants, their clinical significance, and recommendations for further action or counselling.

Practical Takeaway: Ask your referring physician for recommendations, or inquire directly with potential labs about their experience with your specific type of case. Look for labs that clearly articulate their interpretation process and provide accessible clinical support.

Sample Collection and Logistics

Understanding the practical aspects of sample collection is important.

Sample Type: Most genetic tests use a blood sample (EDTA tube), but some may use saliva or buccal swabs, especially for non-invasive options or when blood draws are challenging.
Collection Centers: Verify if the lab has collection centers near you or if they offer home collection services. If not, you’ll need to coordinate with a local clinic for sample collection and shipment.
Shipping: For samples sent across cities, ensure the lab uses reliable, temperature-controlled shipping methods to maintain sample integrity.

Practical Takeaway: Confirm the sample requirements and logistics beforehand. Ensure you follow all pre-collection instructions (e.g., fasting, if required) precisely to avoid issues with your sample.

The Role of Genetic Counselling

Genetic counselling is an indispensable part of the genetic testing process, especially when considering panel testing or WES.

Before the Test (Pre-Test Counselling)

A genetic counsellor will:

Assess your family history and medical background: To determine the most appropriate test and its scope.
Explain the test: Including its purpose, methodology, potential findings, limitations, and the probability of obtaining a diagnostic result, a VUS, or an incidental finding.
Discuss the implications: Cover the medical, psychological, and social implications of potential results, including implications for family members.
Obtain informed consent: Ensure you understand and agree to the testing process.

After the Test (Post-Test Counselling)

Once results are available, a genetic counsellor will:

Interpret and explain the results: In a clear, understandable manner, regardless of their complexity (positive, negative, VUS, incidental finding).
Discuss clinical implications: How the results may impact diagnosis, prognosis, treatment, or management plans.
Provide recommendations: Suggest further tests, referrals to specialists, or family testing as needed.
Offer psychosocial support: Help you cope with the emotional and psychological impact of the results.

Practical Takeaway: Do not skip genetic counselling. It is crucial for making informed decisions and understanding the nuances of complex genetic information. If your referring physician does not offer this service, ask for a referral to a qualified genetic counsellor. Many labs also offer in-house or outsourced genetic counselling services.

In the ongoing discussion about genetic testing, the article on Single-Gene Testing vs Panel Testing vs Whole Exome Sequencing provides valuable insights into how to choose the appropriate testing method based on individual needs. This resource highlights the differences between these testing approaches, helping patients and healthcare providers make informed decisions. Understanding the nuances of each option is crucial for effective diagnosis and treatment planning in genetics.

Future Considerations and Evolving Landscape

Testing Type	Scope	Turnaround Time	Cost	Diagnostic Yield	Use Case	Limitations
Single-Gene Testing	One specific gene	1-3 weeks	Low	Variable; high if clinical suspicion is strong	When a specific gene is strongly suspected based on phenotype	Limited scope; may miss other relevant mutations
Panel Testing	Multiple genes related to a condition	2-4 weeks	Moderate	Higher than single-gene; depends on panel size	Conditions with genetic heterogeneity or overlapping symptoms	May not detect novel or unexpected gene mutations
Whole Exome Sequencing (WES)	All coding regions (~20,000 genes)	4-8 weeks	High	Highest diagnostic yield for complex or undiagnosed cases	Unexplained genetic disorders, broad phenotype, or negative panel tests	May miss non-coding variants; interpretation complexity; incidental findings

Genetic testing is a rapidly advancing field. What is considered standard today may be surpassed by new technologies tomorrow.

Re-analysis of Data

One significant advantage of WES data is its potential for re-analysis. If an initial WES doesn’t yield a diagnosis, the raw data can be re-interpreted after a period (e.g., 1-2 years) as new genes are discovered or the understanding of existing variants evolves. This can lead to a diagnosis without the need for a completely new test.

Whole Genome Sequencing (WGS)

While WES sequences only the exome, Whole Genome Sequencing (WGS) sequences nearly all of your DNA, including both coding and non-coding regions. WGS can detect structural variants, mitochondrial DNA variations, and repeat expansions that WES might miss. Currently, WGS is more expensive and complex to interpret than WES. However, its cost is decreasing, and it may become a more common diagnostic tool in the future, particularly for cases where WES has been negative.

Non-Invasive Prenatal Testing (NIPT) and Other Innovations

New technologies like Non-Invasive Prenatal Testing (NIPT), which analyzes fetal DNA from a maternal blood sample, are becoming more widespread. These innovations demonstrate the rapid pace of development in genetic testing. Stay informed about new options and discuss them with your healthcare provider.

Practical Takeaway: Be aware that your genetic information is a lifelong resource. The data generated from comprehensive tests like WES can have long-term utility. Maintain open communication with your healthcare team about any new symptoms or advancements in genetic understanding relevant to your condition.

This article is for general educational purposes and is not a substitute for professional medical or genetic counselling advice.

FAQs

What is single-gene testing?

Single-gene testing involves analyzing a specific gene for mutations or variations that may be responsible for a particular genetic condition or disease.

What is panel testing?

Panel testing involves analyzing a group of genes known to be associated with a particular condition or set of conditions. It allows for the simultaneous testing of multiple genes related to a specific disease or trait.

What is whole exome sequencing?

Whole exome sequencing is a comprehensive genetic test that examines all protein-coding regions of an individual’s genome. It can identify variations in thousands of genes, providing a broad view of potential genetic factors contributing to a condition.

How do I choose between single-gene testing, panel testing, and whole exome sequencing?

The choice between these testing methods depends on the specific clinical scenario, the suspected genetic condition, and the individual’s personal and family medical history. Single-gene testing is appropriate when a specific gene is suspected, panel testing is useful for conditions with genetic heterogeneity, and whole exome sequencing is considered when the genetic cause is unknown or when multiple genes may be involved.

What are the advantages of whole exome sequencing over single-gene testing and panel testing?

Whole exome sequencing offers a more comprehensive analysis of the genetic code, allowing for the identification of rare or novel genetic variants that may not be detected by single-gene testing or panel testing. It can be particularly beneficial in cases where the underlying genetic cause is complex or unknown.